Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

International Network for Training on Risks of vascular Intimal Calcification And roads to Regression of cardiovascular diseasE

Project description

Can Vitamin K prevent atherosclerosis?

Cardiovascular diseases are associated with the formation of atherosclerotic plaques on vessel walls, which may rupture and cause serious complications, including death. Emerging evidence indicates a higher risk of heart attacks and strokes in individuals with plaques showing calcium deposition (microcalcifications). Funded by the Marie Skłodowska-Curie Actions programme, the INTRICARE project aims to investigate what causes microcalcification and how it affects plaque stability. As current treatments and prevention methods are insufficient, the consortium proposes the use of Vitamin K supplementation as a strategy to prevent or improve vulnerable plaque formation.

Objective

Cardiovascular disease remains one of the major challenges of contemporary society, being responsible for a staggering 47% of deaths in Europe. Vascular calcification in particular requires immediate attention as it is strongly associated with increased cardiovascular mortality and morbidity, and is recognised as an important independent risk factor for cardiovascular death. Recent reports demonstrate that especially punctuated and spotty calcifications (microcalcifications) in the plaque are life-threatening. Microcalcifications are particularly prominent in the vulnerable atherosclerotic plaque that is at high risk of rupture, a cardinal event that can cause thrombosis, infarct, cardiac arrest, stroke and death. In fact, 20% of European deaths are directly attributable to thrombotic rupture of a vulnerable plaque; a clear indication that current treatments and preventive measures are insufficient. Recent findings suggest a link between vascular smooth muscle cell phenotype mediated calcification and inflammation, which could underlie the plaque destabilising effects of microcalcification. However, a comprehensive view on what causes microcalcification and its impact on plaque stability remains elusive and there is an urgent need to translate experimental findings into adequate diagnostic, preventive and therapeutic solutions. INTRICARE is shaped to address the urgent unmet medical needs concerning calcification-induced vulnerable plaques and is guided by the academic and industrial demand for a new generation of entrepreneurial scientists that have the skills, expertise and knowhow to expedite our understanding of vascular calcification and translation thereof into concrete, effective clinical solutions. The INTRICARE ESRs harbour ongoing vitamin K-supplementation trials that will be pivotal in the identification of selective biomarkers for microcalcification and subsequent development of strategies for prevention or amelioration of vulnerable plaque formation.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-ITN-2016

See all projects funded under this call

Coordinator

UNIVERSITEIT MAASTRICHT
Net EU contribution
€ 1 532 245,68
Address
MINDERBROEDERSBERG 4
6200 MD Maastricht
Netherlands
Region
Zuid-Nederland Limburg (NL) Zuid-Limburg
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 532 245,68

Participants (2)